BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Que ZJ, Yao JL, Zhou ZY, Yu P, Luo B, Li HG, Liu JX, Xu HX, Tian JH. Jinfukang inhibits lung cancer metastasis by upregulating CX3CL1 to recruit NK cells to kill CTCs. J Ethnopharmacol 2021;275:114175. [PMID: 33933571 DOI: 10.1016/j.jep.2021.114175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shen P, Jia Y, Shi S, Sun J, Han X. Analytical and biomedical applications of microfluidics in traditional Chinese medicine research. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116851] [Reference Citation Analysis]
2 Pereira-Veiga T, Schneegans S, Pantel K, Wikman H. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell Rep 2022;40:111298. [PMID: 36044866 DOI: 10.1016/j.celrep.2022.111298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ran GH, Lin YQ, Tian L, Zhang T, Yan DM, Yu JH, Deng YC. Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduct Target Ther 2022;7:205. [PMID: 35768424 DOI: 10.1038/s41392-022-01058-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chen F, Li J, Wang H, Ba Q. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment. Front Oncol 2021;11:746917. [PMID: 34722304 DOI: 10.3389/fonc.2021.746917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]